Search Results

Dr. Save the date: February 8 - 29: Join Dr. GPCR University's live Zoom sessions hosted by Dr. Kenakin, according to his availability Access to the cohort’s Dr. GPCR Ecosystem group, where you can find Dr. Kenakin and Dr. GPCR Access to Dr.

. 🔍 This Week in Dr. 🎥 Live AMA with Dr. Kenakin — October 30, 12 PM EST Bring your toughest pharmacology questions and join Dr. 50% Discount at Checkout ➤ The Innovation Trap: Why Playing It Safe Can Kill Breakthroughs Revvity's Dr Read the roundup ➤ Why Dr.

For Dr. You’re just changing how bright it is—and how long it glows,” said Dr. Eric Trinquet. Listen to the full podcast episode here ⸻ More about Revvity pHSense Reagents GPCR Reagents Revvity on Dr GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr.

Dr. GPCR Podcast Exciting news! Episode 152 with Dr. Our most recent episode features our very own Dr. GPCR Board. Tune in and enjoy! Dr. Dr. GPCR Symposia Explore GPCRs with our Premium Membership! Access recorded material from previous events, including the Dr. GPCR Summit editions. In the meantime, visit Dr. GPCR Symposia and learn from experts in the field.

This week's highlight: Drs. GPCR University's live Zoom sessions hosted by Dr. Terry Kenakin. Registrations are open to Dr. GPCR Ecosystem Members! GPCR Ecosystem group, where you can find Dr. Kenakin and Dr. GPCR Access to Dr.

Dr. Congrats to Dr. GPCR Symposium on 'GPCRs as Therapeutic Modalities' with Richa Tyagi, Dr. Terry Kenakin, Dr. Oliver Hartley, Dr. Pierre Eftekhari, Dr. Lauren Slosky, Dr. Christel Menet, Dr. Ben Myers and Dr. Subscribe to the Dr. GPCR Newsletter and receive valuable insights!

That’s precisely what Terry’s Corner delivers each week: practical frameworks from Dr. SEP-631 for CSU; Maxion’s KnotBody® platform; a new angle on RGS protein modulation. 🔍 This Week in Dr Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 Live AMA with Dr. Register now and save with code SPK200 ➤ Why Dr. Access this week’s full Premium Edition here ➤ What our members say "Dr.

That’s precisely what Terry’s Corner delivers every week: practical tools from Dr. Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity. 🔍 This Week in Dr Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 First-ever Live AMA with Dr. This week, get to know Dr. Aaron McGrath from Takeda. He joins Dr. Register now and save with code SPK200 ➤ Why Dr.

.; Popov, P.; Benchama, O.; Zvonok, N.; Locke, K.; Qu, L.; Han, G. W.; Iyer, M. V.; Van Der Stelt, M.; Pacher, P.; Gertsch, J.; Ullmer, C.; McCormick, P. J.; Oddi, S.; Spaink, H. P.; Maccarrone, M.; Veprintsev, D. B.; Carreira, E. M.; Grether, U.; Nazaré, M. -P. -F.; Farce, A.; Chavatte, P.; Poupaert, J. H.; Lambert, D. M.; Depreux, P.; Hénichart, J.-P.

Confirmed speakers include Drs. Dr. Dr. GPCR Volunteers Join our dynamic team as a volunteer! Dr. Dr. GPCR Members get 10% off with code MPDRGPCR10.

2016) where O-glycosylation contributes to the differential binding to CC or CX3C chemokine (Casarosa P phosphosulfate (PAPS) donor to the hydroxyl group of a tyrosine residue of the protein chain (Seibert C and Sakmar sites in their N-termini that mediate ligand binding and signaling (Bannert N et al. 2001; Casarosa P glycosulfo peptide analogue GSnP-6 displays nanomolar affinity and promising potential for blocking PSGL-1/P-selectin

We are pleased to announce five full scholarship opportunities for Dr. Join our upcoming Dr. GPCR University hands-on workshop with Dr.  The workshop includes: Four x 2-hour Zoom sessions One-on-one meeting with Dr. Hoare Access to Dr. GPCR Ecosystem group Access to course materials and recordings Completion certificate One-year Dr. Dr.

phosphorylation of the G protein subunit Gαi at specific residues within three strategic hotspots: the P Key findings include: Phosphorylation Hotspots: P Loop (Ser44, Ser47, Thr48): Impairs ligand-stimulated Signaling Pathway Segregation: Phosphorylation events in the interdomain cleft and P loop uncouple G J., Ghassemian, M., Kufareva, I., & Ghosh, P. (2024).

In this exclusive foundational-level lecture, Dr. Dr. Kenakin also celebrates the giants on whose shoulders we stand—A.J.

But as Dr. His work in the lab of Dr. Dr.

This week's highlight includes congrats to: Drs. Bryan Roth and Brian Krumm for their study on Molecular glues as potential GPCR therapeutics Drs. work on G protein-coupled receptor endocytosis generates spatiotemporal bias in β-arrestin signaling Drs GPCR University We're thrilled to announce that Dr. Terry Kenakin will lead two brand-new, back-to-back courses tailored for the Dr.

Preston Nibley, Dr. Sudha K Shenoy et al. Dr. Xavier Leroy for his new role as CEO of GIO Therapeutics Dr. Confirmed speakers include Drs. Dr. Dr.

This week's highlight includes congrats to: Drs. Confirmed speakers include Drs.  Dr. Dr. Dr. GPCR Members get 10% off with code MPDRGPCR10.

work on Direct interrogation of context-dependent GPCR activity with a universal biosensor platform Dr Dr. GPCR University Save the date for our upcoming workshop, starting May 9th, 2024, featuring Dr.  Under Dr. Hoare's expert guidance, you will gain invaluable skills in data analysis. Dr. Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr. Dr.

This week's highlight: Dr. GPCR University live Zoom sessions hosted by Dr. Terry Kenakin. Registrations open on December 15th and close on February 1st to both Dr. The package includes four live Zoom sessions, a one-year Dr. Kenakin and Dr. GPCR.

Explore 10 on-demand lessons by Dr. Visit Yamina’s Corner Now CELT-335 - Celtarys Validates New Assay for CB1/CB2 Screening Dr. Stay curious,   The Dr. GPCR Team Join Our Newsletter!

clinical parameters such as alpha-fetoprotein and tumor grade in the HCC patients; (c) besides HCC (p was found to be an important factor for survival in four other cancers (clear renal cell carcinoma: p < 0.001, lung adenocarcinoma: p = 0.004, mesothelioma: p = 0.039, ovarian serous cystadenocarcinoma: p = 0.048); (d) RGS20 was found to be significantly associated with some tumor-related signaling pathways

Cell, 1997. 89(2): p. 251-61. https://pubmed.ncbi.nlm.nih.gov/9108480/ 2. Front Mol Neurosci, 2020. 13: p. 5. https://pubmed.ncbi.nlm.nih.gov/32038168/ 3. Cell, 2021. 184(4): p. 931-942.e18. https://pubmed.ncbi.nlm.nih.gov/33571431/ 6. J Neurosci, 2019. 39(42): p. 8291-8304. https://pubmed.ncbi.nlm.nih.gov/31308097/ 8. Genomics, 2021. 113(4): p. 2134-2144. https://pubmed.ncbi.nlm.nih.gov/33845140/

of patients showed high GPER expression and significant correlation with the mRNA subtype of TNBC (P  = 0.001), total metastatic events (P = 0.019) and liver metastasis (P = 0.011). interval of 67.1 months, a significant trend towards reduced distant metastasis-free survival (DMFS) (P 

This week's highlights: Dr. Randy Hall's study: GPR37L1's role in shaping cortical astrocytes during development Dr. The Dr. GPCR Symposium on 'GPCRs as Therapeutic Modalities' is set for September 22nd. Stay updated with the Dr. GPCR Newsletter for confirmed speaker announcements. Robert Lefkowitz Lab Postdoc Fellow - Dr.

Welcome to this week’s Dr. multiple transducers; plus obesity-drug program milestones and company pipeline updates. 🔍 This Week in Dr stay ahead of the science 🧠 Content built for biotech, pharma & academia 💬 Live monthly AMA with Dr Kenakin     💎 $2999/year — one conference cost = 12 months of expert training  Premium Dr. For Dr.

This week's highlighted papers: Dr. Dr. Mark your calendars for the upcoming Dr. Stay updated by subscribing to Dr. GPCR Newsletter! Robert Lefkowitz Lab NEW Postdoc Fellow - Dr.

Hello Dr. GPCR ecosystem members!  also the hiring manager for their open Principal Scientist, In Vitro Pharmacology role posted in the Dr By: Mark Schmeizl Chief Matchmaker at Dr. GPCR

Dr. Drs. Stay tuned by subscribing to the Dr. GPCR Newsletter! In case you missed it, recordings of the Dr. Robert Lefkowitz Lab Postdoc Fellow - Dr.

That’s the mission of Dr. Dr. . 🎧 Listen to the full episode of the Dr. GPCR Podcast Push the boundaries of what's possible 👉 Join the Dr.